Artelo Biosciences enters $6.5M at-the-market equity offering with R.F. Lafferty

ARTELO BIOSCIENCES, INC.

Agreement with R.F. Lafferty & Co. to sell up to $6.5M of common stock via ATM program.
Manager commission: 2.0% of gross sales price per share; Company may set minimum price.
Offering can be suspended by either party on 5 days' notice; Company has no obligation to sell.
Based on existing Form S-3 shelf effective July 14, 2023; prospectus supplement filed July 18, 2025.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.